SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-015530
Filing Date
2022-08-08
Accepted
2022-08-08 16:12:05
Documents
70
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q fgen-20220630.htm   iXBRL 10-Q 4461672
2 EX-31.1 fgen-ex31_1.htm EX-31.1 11626
3 EX-31.2 fgen-ex31_2.htm EX-31.2 11603
4 EX-32.1 fgen-ex32_1.htm EX-32.1 11833
  Complete submission text file 0000950170-22-015530.txt   13419509

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fgen-20220630_lab.xml EX-101.LAB 536900
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fgen-20220630_pre.xml EX-101.PRE 460764
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fgen-20220630_def.xml EX-101.DEF 286116
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fgen-20220630_cal.xml EX-101.CAL 77157
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fgen-20220630.xsd EX-101.SCH 79045
64 EXTRACTED XBRL INSTANCE DOCUMENT fgen-20220630_htm.xml XML 2686111
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36740 | Film No.: 221144491
SIC: 2834 Pharmaceutical Preparations